{"id":"https://openalex.org/W2157370538","doi":"https://doi.org/10.1001/archpsyc.1994.03950020083008","title":"Clinical Response to Clozapine in Patients With Schizophrenia","display_name":"Clinical Response to Clozapine in Patients With Schizophrenia","publication_year":1994,"publication_date":"1994-02-01","ids":{"openalex":"https://openalex.org/W2157370538","doi":"https://doi.org/10.1001/archpsyc.1994.03950020083008","mag":"2157370538","pmid":"https://pubmed.ncbi.nlm.nih.gov/8297214"},"language":"en","primary_location":{"id":"doi:10.1001/archpsyc.1994.03950020083008","doi":"https://doi.org/10.1001/archpsyc.1994.03950020083008","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.1994.03950020083008","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113554926","display_name":"David Pickar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David Pickar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R E Litman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R E Litman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"W W Hong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W W Hong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"T P Su","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T P Su","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"E M Weissman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E M Weissman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J K Hsiao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J K Hsiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"W Z Potter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Z Potter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5113554926"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7881,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.69343795,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"51","issue":"2","first_page":"159","last_page":"159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.984000027179718},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.8790000081062317},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/mesoridazine","display_name":"mesoridazine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/5-ht2-receptor-antagonism","display_name":"5-HT2 receptor antagonism","score":0.7929999828338623},{"id":"https://openalex.org/keywords/alpha-2-adrenergic-antagonism","display_name":"alpha-2 adrenergic antagonism","score":0.8320000171661377},{"id":"https://openalex.org/keywords/norepinephrine-turnover","display_name":"norepinephrine turnover","score":0.9179999828338623},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9470000267028809}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.9644337296485901},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7179637551307678},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.5498124361038208},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.5027220249176025},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.46491795778274536},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.418737530708313},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.4109596610069275},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39606544375419617},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3866594135761261},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.37587717175483704},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36919182538986206},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2686775326728821},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.24552711844444275},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.21235355734825134},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.19861701130867004},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06334802508354187}],"mesh":[{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004146","descriptor_name":"Dioxanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005476","descriptor_name":"Fluphenazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019329","descriptor_name":"Idazoxan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1001/archpsyc.1994.03950020083008","doi":"https://doi.org/10.1001/archpsyc.1994.03950020083008","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.1994.03950020083008","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},{"id":"pmid:8297214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8297214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of general psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W64322893","https://openalex.org/W1983634030","https://openalex.org/W1984737218","https://openalex.org/W2019953824","https://openalex.org/W2086866139","https://openalex.org/W2088879645","https://openalex.org/W2407987359"],"related_works":["https://openalex.org/W2030193619","https://openalex.org/W2088879645","https://openalex.org/W2742687620","https://openalex.org/W2399495866","https://openalex.org/W2047582962","https://openalex.org/W2008583515","https://openalex.org/W144878538","https://openalex.org/W1523476179","https://openalex.org/W1977120421","https://openalex.org/W2469169783"],"abstract_inverted_index":{"One":[0],"of":[1,15,24,69,90,104,109,115],"the":[2,10,16,22,101,107],"take-home":[3],"messages":[4],"from":[5],"our":[6],"recent":[7],"report":[8],"regarding":[9],"clinical":[11],"and":[12,30,75],"biological":[13],"effects":[14,26],"atypical":[17],"neuroleptic,":[18],"clozapine,":[19,105],"was":[20],"that":[21,60,76,120],"admixture":[23],"clozapine's":[25,61,121],"on":[27],"dopaminergic,":[28],"serotonergic,":[29],"noradrenergic":[31],"systems":[32],"may":[33,81],"underlie":[34],"its":[35],"unique":[36],"efficacy":[37],"in":[38,72,130],"otherwise":[39],"poorly":[40],"responsive":[41],"patients":[42,74],"with":[43,46],"schizophrenia.1We":[44],"agree":[45],"a":[47,113],"suggestion":[48],"by":[49],"R.":[50],"W.":[51],"Pies,":[52],"MD,":[53],"(unpublished":[54],"communication":[55],"to":[56,100,127],"theArchives,":[57],"May":[58],"1992)":[59],"diverse":[62],"pharmacologic":[63],"properties":[64],"indicate":[65],"strategies":[66],"for":[67],"augmentation":[68],"neuroleptic":[70,116],"drugs":[71],"treatment-resistant":[73],"thioridazine":[77],"or":[78],"mesoridazine":[79],"besylate":[80],"be":[82],"particularly":[83],"useful,":[84],"given":[85,99],"their":[86],"relatively":[87,122],"low":[88],"incidence":[89],"extrapyramidal":[91],"side":[92],"effects.":[93],"Whereas":[94],"much":[95],"attention":[96],"has":[97],"been":[98],"5-hydroxytryptamine2(5-HT2)":[102],"antagonism":[103],"including":[106],"ratio":[108],"5-HT2to":[110],"D2affinities":[111],"as":[112],"predictor":[114],"atypicality,2we":[117],"have":[118],"noted":[119],"potent":[123],"\u03b12-antagonism":[124],"(putatively":[125],"contributing":[126],"observed":[128],"increases":[129],"norepinephrine":[131],"turnover)":[132],"is":[133],"distinct":[134],"among":[135]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}